J. Behr (Munich, Germany), J. Domagala-Kulawik (, Poland)
Inhibition of pulmonary collagen-I, III and fibrotic cytokins in bleomycin induced pulmonary fibrosis by okam J201
H. Jiang, L. Wang (Qingdao, China)
|  |
The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats
D. Zhang, Y. Zhuang (Nanjing, China)
| |
Extracorporal photosensitation in bleomycin-induced lung injury decreases IL-10 protein levels in BAL but not the level of inflammation
K. F. Remund, M. Hofer, Z. Guo, R. Reugg, P. Vogt, S. Korom, A. Boehler (Zurich, Switzerland)
| |
Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats
Z. Yildirim, M. Kotuk, H. Erdogan, M. Iraz, M. Yagmurca, I. Kuku, E. Fadillioglu (Malatya, Tokat, Afyon, Turkey)
| |
Effect of phospholipid-cholesterol liposomes (PCL) instillation in the lung on ultrastructural, biochemical and biophysical characteristics of pulmonary surfactant (PS) in experimentally produced acute respiratory distress syndrome (ARDS) in rabbits
T. P. Praznikova, I. T. Steneva (Sofia, Bulgaria)
| |
Blockage of serotonin receptors and transporter reduces bleomycin lung fibrosis in mice
A. Fabre, J. Marchand, S. Marchand-Adam, J. Callebert, J. M. Launay, C. Ruffié, P. Soler, B. Crestani (Paris, France)
| |
Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation
M. Molina-Molina, A. Serrano-Mollar, D. Closa, C. Picado, A. Xaubet (Barcelona, Spain)
| |
Pulmonary eosinophilia
J. A. Gonzalez, C. Parpaglione, G. Vilas, D. Ricardi, R. Cristofolli, D. Rey (Buenos Aires, Argentina)
| |
Extrinsic allergic alveolitis associated with natural killer cell lymphocytosis
M. Hubner, P. Errhalt, D. Vedrilla, W. Huebl, M. Kneussl (Vienna, Austria)
| |
A case of diffuse alveolar hemorrhage following administration of artecoll for cosmetic purpose
S. H. Yoon, Y. E. Kwon, S. I. Lee (Gwangju, Republic Of Korea)
| |
p-ANCA positive Hashimoto‘s thyroiditis with interstitial pulmonary disease
H. C. Hasanoglu, A. Karalezli, S. Soytac, S. Sevgili, B. B. Yildirim, A. N. Tokgonul (Ankara, Turkey)
| |
Lung function and symptom improvement in patients with pulmonary alveolar proteinosis after whole lung lavage or N-acetylcysteine treatment
V. V. Kraeva, E. A. Kogan, K. U. Reznikova, B. M. Kornev, V. V. Dengin, V. I. Ossipenko, E. N. Popova (Moscow, Russian Federation)
| |
Lymphangioleiomyomatosis (LAM) initially presented as retroperitoneal tumour. Two case reports
J. Slodkowska, J. Breborowicz, K. Siemiatkowska, A. Jarzemska, G. Przybylski, M. Korzeniewska-Kosela, J. Patera, E. Radzikowska (Warsaw, Poznan, Bydgoszcz, Poland)
| |
A case of Langerhans cell histiocytosis with sclerosing cholangitis
J. Gunes, A. Gulcu, M. Soyturk, U. Eritmen, A. Onen, A. Kargi, A. H. Cimrin (Izmir, Turkey)
| |
A case of acute interstitial pneumonia which developed during the interferon and ribavirin treatment for chronic hepatitis C
B. Sengun, C. Gonen, A. Kargi, A. Onen, P. Balci, A. Akkoclu, O. Gonen (Izmir, Turkey)
| |
Unusual pulmonary lesions in Sjogren Syndrome (a case report)
S. Azzabi, M. A. Baccar, H. Kallel, M. Azzouz, R. B. Mefteh, Z. Kaouech, L. Gharbi, H. Aouina, H. Bouacha (Tunis, Tunisia)
| |
Lymphoid interstitial pneumonia (LIP) presenting as a tumor
A. Gerogianni, F. Dariotaki, C. Papageorgiou, E. Chondrou, A. Klitsa, D. Chaimala, I. Kostara, K. Fragia, D. Antoniou (Athens, Greece)
| |